Regulatory challenges for refined nicotine products
Ces deux articles analysent les enjeux associés à l'encadrement réglementaire des cigarettes électroniques aux Etats-Unis
Historically, refined nicotine has been sold in only two forms: a pesticide or a pharmaceutical grade medicinal product for tobacco addiction. Until recently, the US Food and Drug Administration (FDA) has consistently blocked the marketing of any non-pharmaceutical nicotine product designed for human consumption. The main exceptions to the rule are the electronic nicotine delivery systems (ENDS or electronic cigarettes): battery-powered devices that deliver refined nicotine in a humectant, usual ...